

Pharmacovigilance is responsible for the collection, assessment, identification, and communication of all drug safety information. In addition, PV focuses on the processing of safety information, adverse event reporting, and keeping up to date with guidelines and regulations.
The Pharmacovigilance Oversight and Inspection Readiness Virtual Summit will focus on how to achieve safety inspection readiness through effective partner collaboration and quality optimization strategies.
Speaking
Faculty

Josue Bautista Arteaga

Janaina Brothers

Helena Van Den Dungen

Kal Elhoregy

Garry Flounders

Siva Kumar

Randy Levitt

Carla Massironi

Jaylaxmi Nalawade

Raphael Pareschi

Sameer Thapar
Top Reasons to PURCHASE

Analyze the importance of a Culture of Quality and its impact on safety

Learn tools to “survive” Inspections and Audits

Ensure streamline communication between partners, CROs and sponsors

Leverage learnings and challenges from PV audits to promote and ensure inspection readiness

Discuss new ICH guidelines and their effect on drug safety and pharmacovigilance

Recognize the value of PV systems to streamline communication and achieve inspection readiness

Bridging the gap between PV innovation and PV quality – Level the play field for every drug safety stakeholder
WHO SHOULD PURCHASE
This event is designed for pharmaceutical, biotech, and medical device professionals with responsibilities in the following areas:
- Pharmacovigilance
- Safety & Risk management
- Drug safety
- PV Compliance
- Safety Surveillance
- Medical Affairs
- Regulatory Affairs
- Inspection and Audit
- Pharmacoepidemiology
- Post-market studies
- Medical product safety assessment
- Drug Research & Development
- Clinical Pharmacology
- Medical information
- Health outcomes